Skip to main content
SpringerLink
Log in

High body mass index did not result in poor outcome in Taiwanese children with acute myeloid leukemia: a single-institution experience

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Overweight/obese patients with acute myeloid leukemia (AML) are reported as experiencing inferior outcomes and greater numbers of treatment-related complications. We retrospectively studied 58 children with newly diagnosed AML who received chemotherapy at Chang Gung Memorial Hospital between January 2003 and December 2011. Patients enrolled were considered overweight if body mass index (BMI) was ≥85th percentile. Fifteen of 58 (25.9 %) patients were judged overweight by this criterion. Patients diagnosed in the last third of this period (2009–2011) had a higher average BMI (P = 0.06). The rates of documented infection in overweight patients and non-overweight patients were not significantly different (53.3 vs. 62.8 %). The 5-year event-free survival (EFS) of overweight patients was superior to that of non-overweight patients (78.8 vs. 55.4 %). Patients (n = 11) who received hematopoietic stem cell transplantation (HSCT) in first remission (CR1) had a significantly higher 5-year EFS (87.5 vs. 55.2 %, P = 0.04). Among 47 children who did not receive HSCT in CR1, 10 (21.3 %) were overweight. The 5-year EFS of overweight patients was consistently superior to that for non-overweight patients (70.0 vs. 51.2 %). In conclusion, overweight/obese children with AML did not experience poor outcomes in the present study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Gibson BE, Webb DK, Howman AJ, De Graaf SS, Harrison CJ, Wheatley K, et al. Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trial. Br J Haematol. 2011;155:366–76.

    Article  CAS  PubMed  Google Scholar 

  2. Tsukimoto I, Tawa A, Horibe K, Tabuchi K, Kigasawa H, Tsuchida M, et al. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group. J Clin Oncol. 2009; 27:4007–13.

    Article  CAS  PubMed  Google Scholar 

  3. Rubnitz JE, Inaba H, Dahl G, Ribeiro RC, Bowman WP, Taub J, et al. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncol. 2010;11:543–52.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Lange BJ, Gerbing RB, Feusner J, Skolnik J, Sacks N, Smith FO, et al. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA. 2005;293:203–11.

    Article  CAS  PubMed  Google Scholar 

  5. Jackson-Leach R, Lobstein T. Estimated burden of paediatric obesity and co-morbidities in Europe. Part 1. The increase in the prevalence of child obesity in Europe is itself increasing. Int J Pediatr Obes. 2006;1:26–32.

    Article  PubMed  Google Scholar 

  6. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012;307:483–90.

    Article  PubMed  Google Scholar 

  7. Butturini AM, Dorey FJ, Lange BJ, Henry DW, Gaynon PS, Fu C, et al. Obesity and outcome in pediatric acute lymphoblastic leukemia. J Clin Oncol 2007;25:2063–9.

    Article  PubMed  Google Scholar 

  8. Hijiya N, Panetta JC, Zhou Y, Kyzer EP, Howard SC, Jeha S, et al. Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. Blood. 2006;108:3997–4002.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Inaba H, Surprise HC, Pounds S, Cao X, Howard SC, Ringwald-Smith K, et al. Effect of body mass index on the outcome of children with acute myeloid leukemia. Cancer. 2012;118:5989–96.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Pine M, Wang L, Harrell FE Jr., Calder C, Manes B, Evans M, et al. The effect of obesity on outcome of unrelated cord blood transplant in children with malignant diseases. Bone Marrow Transplant. 2011;46:1309–13.

    Article  CAS  PubMed  Google Scholar 

  11. Aplenc R, Zhang MJ, Sung L, Zhu X, Ho VT, Cooke K, et al. Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation. Blood. 2014;123:3504–11.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Liang DC, Chan TT, Lin KH, Lin DT, Lu MY, Chen SH, et al. Improved treatment results for childhood acute myeloid leukemia in Taiwan. Leukemia. 2006;20:136–41.

    Article  CAS  PubMed  Google Scholar 

  13. de Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 2010;92:1257–64.

    Article  PubMed  Google Scholar 

  14. Hsieh PL, Chen ML, Huang CM, Chen WC, Li CH, Chang LC. Physical activity, body mass index, and cardiorespiratory fitness among school children in Taiwan: a cross-sectional study. Int J Environ Res Public Health. 2014;11:7275–85.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Bulley S, Gassas A, Dupuis LL, Aplenc R, Beyene J, Greenberg ML, et al. Inferior outcomes for overweight children undergoing allogeneic stem cell transplantation. Br J Haematol. 2008;140:214–7.

    PubMed  Google Scholar 

  16. White M, Murphy AJ, Hallahan A, Ware RS, Fraser C, Davies PS. Survival in overweight and underweight children undergoing hematopoietic stem cell transplantation. Eur J Clin Nutr. 2012;66:1120–3.

    Article  CAS  PubMed  Google Scholar 

  17. Hourdequin KC, Schpero WL, McKenna DR, Piazik BL, Larson RJ. Toxic effect of chemotherapy dosing using actual body weight in obese versus normal-weight patients: a systematic review and meta-analysis. Ann Oncol. 2013;24:2952–62.

    Article  CAS  PubMed  Google Scholar 

  18. Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2012;30:1553–61.

    Article  PubMed  Google Scholar 

  19. Kendrick JG, Carr RR, Ensom MH. Pharmacokinetics and drug dosing in obese children. J Pediatr Pharmacol Ther. 2010;15(2):94–109.

    PubMed Central  PubMed  Google Scholar 

  20. Neudorf S, Sanders J, Kobrinsky N, Alonzo TA, Buxton AB, Gold S, et al. Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival. Blood. 2004;103:3655–61.

    Article  CAS  PubMed  Google Scholar 

  21. Leung W, Campana D, Yang J, Pei D, Coustan-Smith E, Gan K, et al. High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood. 2011;118:223–30.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Kelly MJ, Horan JT, Alonzo TA, Eapen M, Gerbing RB, He W, et al. Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation. Pediatr Blood Cancer. 2014;61:269–75.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Baker KS, Bresters D, Sande JE. The burden of cure: long-term side effects following hematopoietic stem cell transplantation (HSCT) in children. Pediatr Clin North Am. 2010;57:323–42.

    Article  PubMed  Google Scholar 

  24. Hasle H. A critical review of which children with acute myeloid leukaemia need stem cell procedures. Br J Haematol. 2014;166:23–33.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by the Grants CMRPG4A0041-42 from Chang Gung Memorial Hospital, Taiwan, and grants DOH102-TD-C-111-006 from the National Health Research Institute, Taiwan.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5 Fu-Shin Street, Kwei-Shan, 333, Taoyuan, Taiwan

    Shih-Hsiang Chen, Tang-Her Jaing, Iou-Jih Hung, Chao-Ping Yang & Tsung-Yen Chang

Authors
  1. Shih-Hsiang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tang-Her Jaing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Iou-Jih Hung
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chao-Ping Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tsung-Yen Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chao-Ping Yang.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, SH., Jaing, TH., Hung, IJ. et al. High body mass index did not result in poor outcome in Taiwanese children with acute myeloid leukemia: a single-institution experience. Int J Hematol 102, 48–52 (2015). https://doi.org/10.1007/s12185-015-1795-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-015-1795-z

Keywords

Search

Navigation